Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 224 for “"QALY"”.
-
Uses and abuses of QALY analysis
… services research has been the development of QALYs (quality adjusted life years) as a measure of health status. This thesis investigates, in three essays, the use of QALYs in health care project evaluation and as an indicator of societal health. The first essay examines the validity (defined …
-
Discrimination and Fairness in QALY-Based Healthcare Allocation
… I argue that we should give extra weight to QALYs for patients whose quality-adjusted life expectancy, without treatment, is less than society's average. I also argue that we should prioritise patients who have had very little notice of their expected death for life-extending treatment.
-
Testing a new method for estimating the monetary value of a QALY.
… for the estimation of the monetary value of a QALY (MVQ) informed by public preferences. Methods Two new questions are developed to estimate an MVQ which ask respondents to trade off length of life to either increase their income, or avoid a decrease in their income. These questions are …
-
Measurement properties of quality-adjusted life year (QALY) measures among older adults with chronic neck pain
Background Quality-adjusted life year (QALY) measures are an important outcome for assessing the cost-effectiveness of healthcare interventions. Ideally, the choice of QALY measures will be informed by the measurement properties within the population of interest. Currently, the EQ-5D and SF-6D are …
-
Cost-effectiveness of air pollution control: Improving quantification methods and estimating QALY gains and health care resource impacts in England
… the NHS, since consumer willingness to pay for a QALY is higher than the estimated NHS expenditure required to deliver one QALY. The optimal level of pollution reduction, as well as the decision about whether and for how long to delay investments, is therefore expected to depend on the source of …
-
Εμπειρική μελέτη της μεθόδου της ενδεχόμενης αποτίμησης στον τομέα της υγείας
… a monetary value to Quality-Adjusted Life-Years (QALYs), setting a cost-effectiveness threshold for accepting or rejecting interventions in a healthcare system. The present doctoral thesis aims at: a) developing, assessing and implementing a research tool for defining, using the Contingent …
-
Comprehensive Investigation of Radiation Techniques for Whole Breast and Post-Mastectomy Irradiations
… willingness-to-pay (WTP) threshold of 100,000 $/QALY, while only IMRT has a 30.7% probability of being more cost-effective than SOC at a WTP threshold of $50,000/QALY. For WBRT patients, MA-VMAT exhibited the lowest LAR of lung cancer, contralateral breast cancer and RCE. NC-VMAT plans provided …
-
Custo-efetividade dos inibidores do cotransportador 2 de sódio-glicose em pacientes com insuficiência cardíaca no Brasil
… Resultados: na ICFEr, o iSGLT2 acrescentou 0,48 QALY em relação ao tratamento padrão e a RCEI encontrada foi de R$ 32.745,72/QALY ganho; na ICFEp, houve incremento de 0,3 QALY com iSGLT2 no tratamento da IC e RCEI de R$ 31.495,43/QALY ganho. Os resultados são inferiores ao limitar de …
-
A benefit-harm and cost-effectiveness analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
… net change in the quality-adjusted life years (QALY) associated with the use of azithromycin. The incremental cost-effectiveness ratio (ICER) was defined as the incremental costs (in 2020 Canadian dollars) per QALY gained, and per exacerbation avoided, with costs and health outcomes discounted …
-
Accesos vasculares para hemodiálisis, cuál es el más costo efectivo?
… years period. The quality adjusted life years (QALYs) were established for each access and the economic ratio for each QALY was calculated also. Results: there were 36 incident hemodialysis patients in 2012, 100% started hemodialysis via central venous catheter, 16 patients change their access …
-
Cost-Effectiveness of Delaying Alzheimer’s Disease Progression with Novel Monoclonal Antibodies
… had the higher comparative ICER at $304,200/QALY, followed by lecanemab at $175,300/QALY. Key driving factors of ICER among lecanemab and donanemab were age at the treatment initiation, patient health state utility values in earlier AD states, and the drug acquisition costs across both …
-
Optimizing Value from Cardiac Rehabilitation: A Cost-Utility Analysis Comparing Age, Sex and Clinical Subgroups
… incremental cost per quality-adjusted life year (QALY) gained for cardiac rehabilitation is $37,662. The incremental cost per QALY gained varies by subgroup, from $18,101 per QALY gained to $104,518 per QALY gained. There is significant uncertainty in the estimates due to uncertainty in the …
-
Comparing manufacturer submitted analysis and Common Drug Review reanalysis of results: A review of health technology assessment reports for non-oncology medications from 2018 to 2019
… assess the difference between mean incremental QALY, ICUR, and BIA in manufacturers and CDR reanalysis reports and chi-square tests and logistic regression to assess the relationship between the variables and the final CDR recommendation. Results Of 178 reports assessed, 31 received "do not …
-
Οικονομική μελέτη ογκολογικών ασθενών που υποβάλλονται σε ακτινοθεραπεία στο Πανεπιστημιακό Νοσοκομείο Ηρακλείου
… after treatment. Quality-adjusted life years (QALYs) were calculated. The main analysis compared radiotherapy with a hypothetical palliative care scenario without radiotherapy based on existing data, while comparisons between radiotherapy techniques were conducted as exploratory analyses. Costs …
-
Next generation sequencing panels for the evaluation of colorectal cancer and polyposis syndromes: a cost-effectiveness analysis
… ratio between $40,000 and $66,000 per QALY. Testing only Lynch syndrome genes to the panel was not cost-effective (>$124,000 per QALY), but when adding genes associated with autosomal dominant conditions with high penetrance of colorectal cancer, the test was cost effective (<$69,000 …
-
The cost-effectiveness of primary screening for chronic kidney disease in Manitoba’s rural and remote First Nations
… First Nations was associated with a $33,500/QALY incremental cost-effectiveness ratio in comparison to usual care. Restricting to communities accessible primarily by air travel, this ratio fell to $16,180/QALY. In conclusion, at a willingness-to-pay threshold of $50,000/QALY, screening for …
-
A cost-utility analysis of liver resection for malignant tumours: a pilot project
… Liver resection provided an average of 2.51 QALY’s compared to 1.99 QALY’s for RFA, and 1.18 QALY’s for chemotherapy, and 0.82 QALY’s for symptom control alone. The costs were $20,122, $ 15,845, $15,069, and $3,899, respectively. The cost-utilities of liver resection and RFA were similar at …
-
Bayesian inference for health state utilities using pairwise comparison data.
… of a treatment, measured in cost per QALY gained. If a treatment costs more than £30000 per QALY the NHS does not consider it to be cost effective. QALYs are calculated using life years and QALY weights. which represent the quality of life of a condition. An example of a QALY weight is …
-
Radon and Lung Cancer
… thresholds between 51,889 and 92,072 $/QALY for Canada, between 27,558 and 85,965 $/QALY for Manitoba, and between 15,801 and 36,547 $/QALY for the Yukon. The discounted ICER for screening and mitigation of existing housing at current rates relative to no radon control measures is 62,451 …
-
A Study of Process Utility
… cost-effectiveness outcomes (Incremental cost/QALY). This is consistent with other work that has suggested the QALY does not capture all outcomes relevant to interventions, particularly where the outcomes are non-health outcomes e.g. associated with processes of receiving care. Aim: With this …
Page 1 of 12